Finally, we demonstrate that targeting Cav-1 through genetic down-regulation in human pancreatic cancer cells can attenuate tumor growth and sensitize tumor cells to chemotherapeutics and radiation. The gene discussed is CAV1; the disease is familial pancreatic carcinoma.